在医疗服务不足的人群中估计药物遗传检测的偏好和支付意愿:一个离散选择实验
Brian E Gawronski1, Ramzi G Salloum2, Julio D Duarte1
1Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, United States.
Frontiers in pharmacology
|April 10, 2024
概括
医疗服务不足的人群表示愿意为药物遗传学 (PGx) 测试支付不到100美元的费用,优先考虑医生的建议和可操作的结果,而不是成本. 这项研究为公平的PGx测试实施提供了信息.
科学领域:
- 药物基因组学 药物基因组学
- 健康差异 在健康上的差异
- 医疗保健服务研究 医疗服务研究
背景情况:
- 药物遗传学 (PGx) 测试的实施可能会加剧由于不平等的获取而导致的健康差异.
- 医疗服务不足的人群在采用PGx测试等新健康技术方面面临障碍.
- 有限的研究存在于PGx测试偏好和成本可接受性在服务不足的群体.
研究的目的:
- 评估在全国范围内医疗服务不足的人群中支付PGx测试的意愿.
- 在这个人群中确定对PGx测试特征的关键偏好,包括成本.
主要方法:
- 一项离散选择实验 (DCE) 调查对美国成年人进行了管理,家庭收入≤42,000美元.
- DCE的属性包括:医生的建议,等待时间,可操作的结果,测试益处和自付费用.
- 有条件和混合逻辑回归模型分析了偏好和支付意愿.
主要成果:
- 包括1060名受访者;82%的人愿意为PGx测试支付<100美元,价格上限为200美元.
- 出口成本是最重要的属性,而等待时间是最不重要的.
- 医生建议,更可操作的结果,以及解决健康问题 (而不是避免副作用) 增加了测试效用.
结论:
- 这项研究提供了对PGx测试偏好和支付意愿的第一个见解,在一个庞大,医疗服务不足的人群中.
- 结果可以指导开发公平和可访问的PGx测试实施策略.
- 了解患者的偏好对于成功将PGx测试整合到医疗保健中至关重要.
相关概念视频
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
Pharmacokinetic Models: Comparison and Selection Criterion
70
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
70
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62


